An official website of the United States government
Home
Name
GVD
Alternate names
None
Primary Site
None
Histology
None
Radiation
None
Remarks
None
Drugs for GVD
Name
Alternate Names
Abbreviations
None
Category
Chemotherapy
Subcategory
Antitumor antibiotic
NSC Number
712227, 620212
Primary Site
None
Histology
None
Remarks
DOXIL Injection received FDA approval February 4, 2013 for the treatment of ovarian cancer in patients whose disease has progressed or recurred after platinum-based chemotherapy and also for AIDS-related Kaposi's sarcoma after failure of prior systemic chemotherapy or intolerance to such therapy.
Feb. 2015: FDA granted Orphan Drug Designation to liposomal doxorubicin for the treatment of Ewing's sarcoma, a rare cancer that develops in or around children's bones.
Feb. 2015: FDA granted Orphan Drug Designation to liposomal doxorubicin for the treatment of Ewing's sarcoma, a rare cancer that develops in or around children's bones.
Coding
This drug should be coded
Name
Alternate Names
Gemcitabine Hydrochloride
Gemzar
LY 188011
LY-188011
LY188011 hydrochloride
Gemcitabine HCL
Abbreviations
None
Category
Chemotherapy
Subcategory
Antimetabolite
NSC Number
613327
Primary Site
Histology
None
Remarks
FDA approved for breast. ovarian, pancreas, NSC lung
Gemcitabine HCL is given intravesically as treatment for bladder tumors. Code as chemotherapy.
Gemcitabine HCL is given intravesically as treatment for bladder tumors. Code as chemotherapy.
Coding
This drug should be coded
Name
Alternate Names
Navelbine
Navelbine ditartrate
Vinorelbine Ditartrate
Vinorelbine Tartrate
Abbreviations
VNB
Category
Chemotherapy
Subcategory
Plant alkyloid
NSC Number
608210
Primary Site
Breast
lung cancer
Histology
None
Remarks
Coding
This drug should be coded
